S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Is Gold Really Boring? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Is Gold Really Boring? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Is Gold Really Boring? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Is Gold Really Boring? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead

BioCorRx (BICX) News Today

$0.79
+0.01 (+1.28%)
(As of 02/21/2024 ET)
SourceHeadline
MarketBeat logoBioCorRx (OTCMKTS:BICX) Shares Cross Above 50 Day Moving Average of $0.80
americanbankingnews.com - February 16 at 5:44 AM
nz.finance.yahoo.com logoBioCorRx Inc. (BICX) stock price, news, quote & history – Yahoo Finance
nz.finance.yahoo.com - February 13 at 3:29 AM
finance.yahoo.com logoBioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
finance.yahoo.com - February 8 at 2:23 PM
msn.com logoCollective Audience And 3 Other Stocks Under $1 Insiders Are Buying
msn.com - January 18 at 1:12 PM
finance.yahoo.com logoBioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
finance.yahoo.com - January 9 at 10:24 AM
seekingalpha.com logoTAYNX Transamerica High Yield ESG-Class R4
seekingalpha.com - January 4 at 10:45 AM
investing.com logoCheng Fwa Industrial Ltd (5426)
investing.com - January 3 at 1:16 PM
finanznachrichten.de logoBioCorRx Inc: BioCorRx Reports Business Update for the Third Quarter of 2023
finanznachrichten.de - November 16 at 3:48 PM
finance.yahoo.com logoBioCorRx Reports Business Update for the Third Quarter of 2023
finance.yahoo.com - November 14 at 4:59 PM
benzinga.com logoBioCorRx President Awarded $14K Worth of Stock Options
benzinga.com - October 3 at 2:21 PM
finanznachrichten.de logoBioCorRx Inc: BioCorRx Reports Business Update for the Second Quarter of 2023
finanznachrichten.de - August 21 at 5:33 AM
finance.yahoo.com logoBioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder
finance.yahoo.com - August 15 at 10:12 AM
finance.yahoo.com logoBioCorRx Reports Business Update for the Second Quarter of 2023
finance.yahoo.com - August 14 at 6:04 PM
investing.com logoTokai Holdings Corp (3167)
investing.com - July 29 at 9:20 PM
investing.com logoFukui Bank Ltd (8362)
investing.com - July 29 at 6:18 AM
investing.com logoNissha Printing Co Ltd (7915)
investing.com - July 28 at 1:38 PM
investing.com logoDSC Investment Inc (241520)
investing.com - July 18 at 11:58 PM
finance.yahoo.com logoBioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
finance.yahoo.com - July 18 at 8:57 AM
finanznachrichten.de logoBioCorRx Inc: BioCorRx Provides Business Update for the First Quarter of 2023
finanznachrichten.de - May 16 at 10:31 AM
finance.yahoo.com logoBioCorRx Provides Business Update for the First Quarter of 2023
finance.yahoo.com - May 16 at 10:31 AM
finance.yahoo.com logoBioCorRx Provides Business Update for 2022
finance.yahoo.com - April 3 at 12:53 PM
finance.yahoo.com logoBioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator Meeting
finance.yahoo.com - March 7 at 5:28 PM
finance.yahoo.com logoBioCorRx to Present at Sequire Biotechnology Conference on February 2nd
finance.yahoo.com - January 27 at 1:42 PM
finance.yahoo.com logoBioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
finance.yahoo.com - January 19 at 12:37 PM
finance.yahoo.com logoBioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United States
finance.yahoo.com - December 7 at 4:36 PM
finance.yahoo.com logoBioCorRx Board of Directors Approves Exploration of Potential Spin-Off of BioCorRx Pharmaceuticals, Inc.
finance.yahoo.com - November 22 at 7:27 PM
finanznachrichten.de logoBioCorRx Inc: BioCorRx Provides Business Update for the Third Quarter of 2022
finanznachrichten.de - November 15 at 12:24 PM
finance.yahoo.com logoBioCorRx Provides Business Update for the Third Quarter of 2022
finance.yahoo.com - November 15 at 12:24 PM
finance.yahoo.com logoBioCorRx to Present at the LD Micro Main Event XV on October 25th
finance.yahoo.com - October 24 at 5:57 PM
finance.yahoo.com logoBioCorRx to Participate at the LD Micro Main Event XV
finance.yahoo.com - October 20 at 1:45 PM
finance.yahoo.com logoBioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
finance.yahoo.com - October 13 at 1:20 PM
nz.finance.yahoo.com logo2B3D Shares Addiction Treatment Deliverables from BioCorRx for Phase I of Mental Health Metaverse Platform Beta
nz.finance.yahoo.com - September 29 at 5:37 PM
finance.yahoo.com logoBICX: Pivotal trial underway
finance.yahoo.com - September 16 at 11:37 AM
apnews.com logoBioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conference
apnews.com - September 6 at 9:36 AM
reuters.com logoBICX.PK - Biocorrx Inc | Stock Price & Latest News | Reuters
reuters.com - September 4 at 10:33 PM
finance.yahoo.com logoBioCorRx Provides Business Update for the Second Quarter of 2022
finance.yahoo.com - August 16 at 10:16 AM
finance.yahoo.com logoBioCorRx to Participate in the Benzinga All Access Event on July 15th
finance.yahoo.com - July 13 at 11:38 AM
finance.yahoo.com logoBioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcast
finance.yahoo.com - July 6 at 6:00 PM
finance.yahoo.com logoBioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
finance.yahoo.com - June 30 at 9:47 AM
finance.yahoo.com logoBioCorRx Featured on LiveNOW from FOX
finance.yahoo.com - June 17 at 5:29 PM
finance.yahoo.com logoBioCorRx to Present at the LD Micro Invitational XII on June 7th
finance.yahoo.com - May 31 at 11:56 AM
finance.yahoo.com logoBioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting
finance.yahoo.com - May 19 at 6:20 PM
finance.yahoo.com logoBioCorRx Business Update for the First Quarter of 2022
finance.yahoo.com - May 17 at 6:27 PM
chron.com logoFirst Trials Set to Begin for BICX104, An Unprecedented Way for Patients to Receive Naltrexone
chron.com - April 28 at 1:51 PM
seekingalpha.com logoBioCorRx starts recruiting in trial of biodegradable naltrexone pellet BICX104 for opioid disorder
seekingalpha.com - April 27 at 6:09 PM
stockhouse.com logoBioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
stockhouse.com - April 27 at 1:08 PM
finanznachrichten.de logoBioCorRx Inc.: BioCorRx to Present at the Planet MicroCap Showcase 2022 in Las Vegas on May 4th
finanznachrichten.de - April 26 at 12:06 PM
finance.yahoo.com logoBioCorRx to Present at the Planet MicroCap Showcase 2022 in Las Vegas on May 4th
finance.yahoo.com - April 26 at 12:06 PM
finance.yahoo.com logoBioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast
finance.yahoo.com - April 19 at 9:37 AM
finance.yahoo.com logoBioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
finance.yahoo.com - April 11 at 9:35 AM
Get BioCorRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter.



BICX Media Mentions By Week

BICX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BICX
News Sentiment

0.67

0.50

Average
Medical
News Sentiment

BICX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BICX Articles
This Week

1

0

BICX Articles
Average Week

Get BioCorRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:BICX) was last updated on 2/22/2024 by MarketBeat.com Staff